31 July 2023 - final results
We reduced our recommendation on the infection prevention group Byotrol some time ago and suggested waiting for the next results announcement before investing. The company has now issued its results for the year to 31 March and these seem to indicate better times ahead. The year was one of significant change with the company seeing a return to more normal levels of activity following the above average levels seen in the times of Covid. Revenue for the period therefore declined to £4.6m (2022: £6.3m) for an adjusted pre-tax loss of £1.23m . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
